Trial Profile

Phase II / III clinical trial of NFL-101 for smoking cessation

Status: Active, no longer recruiting

Phase of Trial: Phase II/III

Latest Information Update: 27 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 Apr 2023 According to a NFL Biosciences media release, company has submitted a request for scientific advice to the EMA with a view to determining the future development of NFL-101 before its marketing authorization. This scientific advice will be issued in the second quarter of 2023.
25 Apr 2023 According to a NFL Biosciences media release, funds raised on Jan 31, 2023 has been allocated to finalizing this Phase II/III clinical trial. Together, these resources will make it possible to finalize the CESTO II study.
25 Apr 2023 According to a NFL Biosciences media release, patient recruitment started in Jan 2022, gradually mobilizing a total of eight Clinical Investigation Centers. The final recruitments were completed by the end of April 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com